Global Anesthesia Video Laryngoscope Market 2020 to 2025: Industry Trends, Share, Size, Growth, Opportunity and Forecast

December 11, 2020

The global anesthesia video laryngoscope market grew at a CAGR of around 6% during 2014-2019. Looking forward, the publisher expects the global anesthesia video laryngoscope market to exhibit moderate growth during the next five years.

An anesthesia video laryngoscope is an intubation device used to provide an around-the-corner view of the anterior larynx. It comprises blades, batteries, a camera and an attached monitor to display an enlarged image of the airway structure and facilitate endotracheal intubation (ETI). Unlike conventional direct laryngoscopy (DL), video laryngoscopy (VL) eliminates the requirement for a direct line of sight for practitioners and helps them carry out a detailed examination. Consequently, anesthesia video laryngoscopes are widely utilized in emergency or secondary care settings to manage complicated cases of laryngoscopy. They are also used as teaching tools in medical institutes, owing to their small size and portability.

Due to the rising cases of coronavirus disease (COVID-19), there is a rise in the demand for anesthesia video laryngoscopes to provide ETI to patients in the nonoperating room or off-site settings. It also keeps the faces of healthcare professionals away from the airways of patients, thereby minimizing the risk of transmission. These devices can also store the video stream on SD memory cards.

Apart from this, the rising prevalence of obesity, along with improvements in the healthcare infrastructure, has increased the adoption of anesthesia video laryngoscope. Besides this, the leading players are focusing on the introduction of product variants that aid in pediatric care. This, in confluence with the growing popularity of minimally invasive surgeries (MIS), is expected to impel the market growth in the coming years.

Companies Mentioned

  • Ambu A/S
  • ATMOS MedizinTechnik GmbH & Co. KG
  • BOMImed Inc.
  • Clarus Medical LLC
  • Daiken Medical Co Ltd.
  • KARL STORZ SE & Co. KG
  • Medtronic Plc
  • Olympus Corporation
  • Orlvision GmbH
  • Prosurg Inc.
  • Teleflex Incorporated
  • Velosal Medical Incorporated
  • Verathon Inc. (Roper Technologies)
  • XION GmbH

Key Questions Answered in This Report:

  • How has the global anesthesia video laryngoscope market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global anesthesia video laryngoscope market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the blade type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global anesthesia video laryngoscope market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.3.1 Primary Sources

2.3.2 Secondary Sources

2.4 Market Estimation

2.4.1 Bottom-Up Approach

2.4.2 Top-Down Approach

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Anesthesia Video Laryngoscope Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Forecast

6 Market Breakup by Product

6.1 Rigid Laryngoscope

6.1.1 Market Trends

6.1.2 Market Forecast

6.2 Transnasal Flexible Laryngoscope

6.2.1 Market Trends

6.2.2 Market Forecast

7 Market Breakup by Blade Type

7.1 Channelled Blade Laryngoscope

7.1.1 Market Trends

7.1.2 Market Forecast

7.2 Non-Channelled Blade Laryngoscope

7.2.1 Market Trends

7.2.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals

8.1.1 Market Trends

8.1.2 Market Forecast

8.2 Critical Care Centers

8.2.1 Market Trends

8.2.2 Market Forecast

8.3 Others

8.3.1 Market Trends

8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America

9.2 Asia Pacific

9.3 Europe

9.4 Latin America

9.5 Middle East and Africa

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

For more information about this report visit here.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.